对某二级医院中成药处方前置审核结果的回顾性分析

Retrospective analysis of the pre-audit results for prescriptions of Chinese patent medicines in a second-level hospital

目的分析某二级医院中成药处方前置审核结果,提示中成药用药风险,促进安全规范使用中成药。方法收集控江医院2021年4月的门急诊处方31542张,依据中成药说明书和相关资料,对中成药毒性成分归类,并对用药问题进行汇总和分析。结果中成药和化学药处方问题类型有所不同,主要表现为重复用药和用法用量问题。中成药说明书中对毒性药材成分警示不足,以及审核软件知识库的不完善增加了中成药使用的风险。结论应完善审方系统中成药相关知识库,加强含毒性药材中成药的高警示管理,提高全民对中成药合理使用的认识。

Objective Analyze the pre-audit results of Chinese patent medicine prescriptions in a second-level hospital,suggest the risks of taking Chinese patent medicines and promote the safe and standardized use of Chinese patent medicines.Methods A total of 31542 outpatient and emergency prescriptions of Kongjiang hospital in April 2021 were collected,combined with the review of the instructions and relevant data,classify the toxic components of Chinese patent medicines,and summarize and analyze the problems of drug use.Results The types of problems in the prescription of Chinese patent medicine and chemical medicines were different,mainly including repeated medication and wrong usage and dosage.Insufficient warnings on toxic medicinal ingredients in the instructions of Chinese patent medicines and the imperfect knowledge base of audit software increased the risk of using Chinese patent medicines.Conclusion It is necessary to improve the knowledge base of the prescription audit system,strengthen the high-alarm management of Chinese patent medicines containing toxic ingredients,and improve the public's understanding of the rational use of Chinese patent medicines.